磺酰胺类槟榔碱衍生物的合成及其缓解心肌肥大活性评价OA
Synthesis of Sulfonamide Arecoline Derivatives and Their Activity Evaluation in Alleviating Myocardial Hypertrophy
目的 揭示合成的新型磺酰胺类槟榔碱衍生物对棕榈酸(PA)诱导心肌细胞肥大的抑制作用.方法 以氢溴酸槟榔碱为原料合成26 种新型磺酰胺类槟榔碱衍生物(D1~D26)并进行结构表征.构建 H9c2 心肌细胞肥大模型,通过CCK-8 试剂盒筛选出最优活性化合物;RT-qPCR 检测心肌肥大标志基因 Nppa、Nppb 和 Myh7 并通过分子对接探讨其潜在作用靶点.结果 化合物D24 可抑制PA 诱导的心肌细胞肥大,下调肥大标志基因Nppa、Nppb 和Myh7 的表达,分子对接结果显示 D24 与受体蛋白 Nrf2 具有良好的亲和力.结论 本研究合成了一种新型磺胺类槟榔碱衍生物 D24,并发现其可抑制 PA 诱导的心肌细胞肥大.
Objective To investigate the inhibitory effects of newly synthesized sulfonamide arecoline derivatives on palmitic acid(PA)-induced cardiomyocyte hypertrophy.Methods Twenty-six novel sulfonamide arecoline derivatives(D1-D26)were synthesized starting from arecoline hydrobromide and structurally characterized.An H9c2 cardiomyocyte hypertrophy model was established to screen for the lead compound via CCK-8 assay.Furthermore,the expression of hypertrophy markers(Nppa,Nppb,and Myh7)were detected by RT-qPCR,and potential targets were explored via molecular docking.Results Compound D24 significantly inhibited PA-induced cardiomyocyte hypertrophy and down-regulated the expression of hypertrophic marker genes(Nppa,Nppb and Myh7).Molecular docking analysis revealed that D24 possessed favorable binding affinity to the Nrf2 protein.Conclusion A novel sulfonamide arecoline derivative,D24,was synthesized and found to inhibit PA-induced cardiomyocyte hypertrophy.
杜新宇;杨壮壮;张焱蕾;刘仔翔;任展宏;曾志刚
湖北科技学院医学部药学院,湖北 咸宁 437100湖北科技学院医学部药学院,湖北 咸宁 437100湖北科技学院核技术与化学生物学院湖北科技学院核技术与化学生物学院湖北科技学院医学部基础医学院湖北科技学院核技术与化学生物学院
医药卫生
槟榔碱磺酰胺合成棕榈酸心肌细胞肥大
ArecolineSulfonamideSynthesisPalmitic acidCardiomyocyte hypertrophy
《湖北科技学院学报(医学版)》 2026 (4)
306-310,315,6
项目基金:湖北省科技计划项目(2025CDB024)湖北省自然科学基金-咸宁联合资助项目(2025AFD407)咸宁市科技计划项目(2024RCFW004)咸宁市自然科学基金"大健康专项"(2025DJK07)
评论